 |
|
|
| |
Two Year Tenofovir Disoproxil Fumarate (TDF) Treatment and Adefovir Dipivoxil (ADV) Switch Data in HBeAg-Negative Patients with Chronic Hepatitis B (Study 102)
|
| |
| |
Reported by Jules Levin
13th International Symposium on Viral Hepatitis and Liver Disease
March 20th-24th 2009
Washington DC
Patrick Marcellin1, Maria Buti2, Zahary Krastev3, Selim Gurel4, Rozalina Balabanska5, Geoff Dusheiko6, Robert Myers7, E Jenny Heathcote8, Jeff Sorbel9, Jane Anderson9, Elsa Mondou9 and Franck Rousseau9
1Hopital Beaujon, Clichy, France; 2Hospital Valle Hebron, Barcelona, Spain; 3University Hospital "St Ivan Rilsky", Sofia, Bulgaria; 4University of Uludag, Bursa, Turkey; 5Tokuda Hospital, Sofia, Bulgaria; 6Royal Free Hospital, London U.K.; 7University of Calgary, Calgary Alberta, Canada; 8Toronto Western Hospital, University of Toronto, Toronto Ontario, Canada; 9Gilead Sciences, Durham NC
|
| |
|
|
|
|
|
